Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI, USA.
Department of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Korean J Radiol. 2021 Jul;22(7):1213-1224. doi: 10.3348/kjr.2020.1104. Epub 2021 Mar 9.
To develop a machine learning (ML) pipeline based on radiomics to predict Coronavirus Disease 2019 (COVID-19) severity and the future deterioration to critical illness using CT and clinical variables.
Clinical data were collected from 981 patients from a multi-institutional international cohort with real-time polymerase chain reaction-confirmed COVID-19. Radiomics features were extracted from chest CT of the patients. The data of the cohort were randomly divided into training, validation, and test sets using a 7:1:2 ratio. A ML pipeline consisting of a model to predict severity and time-to-event model to predict progression to critical illness were trained on radiomics features and clinical variables. The receiver operating characteristic area under the curve (ROC-AUC), concordance index (C-index), and time-dependent ROC-AUC were calculated to determine model performance, which was compared with consensus CT severity scores obtained by visual interpretation by radiologists.
Among 981 patients with confirmed COVID-19, 274 patients developed critical illness. Radiomics features and clinical variables resulted in the best performance for the prediction of disease severity with a highest test ROC-AUC of 0.76 compared with 0.70 (0.76 vs. 0.70, = 0.023) for visual CT severity score and clinical variables. The progression prediction model achieved a test C-index of 0.868 when it was based on the combination of CT radiomics and clinical variables compared with 0.767 when based on CT radiomics features alone ( < 0.001), 0.847 when based on clinical variables alone ( = 0.110), and 0.860 when based on the combination of visual CT severity scores and clinical variables ( = 0.549). Furthermore, the model based on the combination of CT radiomics and clinical variables achieved time-dependent ROC-AUCs of 0.897, 0.933, and 0.927 for the prediction of progression risks at 3, 5 and 7 days, respectively.
CT radiomics features combined with clinical variables were predictive of COVID-19 severity and progression to critical illness with fairly high accuracy.
开发一种基于放射组学的机器学习 (ML) 管道,使用 CT 和临床变量预测 2019 年冠状病毒病 (COVID-19) 的严重程度和未来向危重症的恶化情况。
从一个具有实时聚合酶链反应确认的 COVID-19 的多机构国际队列中收集了 981 名患者的临床数据。从患者的胸部 CT 中提取放射组学特征。队列数据使用 7:1:2 的比例随机分为训练集、验证集和测试集。使用放射组学特征和临床变量对包括严重程度预测模型和疾病进展至危重症的时间预测模型的 ML 管道进行训练。计算受试者工作特征曲线下面积 (ROC-AUC)、一致性指数 (C-index) 和时间依赖性 ROC-AUC 来确定模型性能,并与放射科医生的视觉解释共识 CT 严重程度评分进行比较。
在 981 名确诊 COVID-19 的患者中,有 274 名患者发展为危重症。放射组学特征和临床变量在预测疾病严重程度方面表现最佳,测试 ROC-AUC 最高为 0.76,而视觉 CT 严重程度评分和临床变量为 0.70(0.76 比 0.70, = 0.023)。当基于 CT 放射组学和临床变量的组合时,进展预测模型的测试 C-index 为 0.868,而仅基于 CT 放射组学特征时为 0.767(<0.001),仅基于临床变量时为 0.847( = 0.110),仅基于视觉 CT 严重程度评分和临床变量时为 0.860( = 0.549)。此外,基于 CT 放射组学和临床变量组合的模型对预测 3、5 和 7 天的进展风险分别实现了时间依赖性 ROC-AUC 为 0.897、0.933 和 0.927。
CT 放射组学特征结合临床变量对 COVID-19 的严重程度和进展为危重症具有较高的预测准确性。